Evidence mapPaperPMID 28951821Full record

ReviewMolecular metabolism2017

The dynamic plasticity of insulin production in β-cells.

Brandon B Boland, Christopher J Rhodes, Joseph S Grimsby

Open access · goldAbstract readReview
In one paragraph

Review in Molecular metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 195 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brandon B BolandMedImmune, Cardiovascular and Metabolic Disease Research, 1 MedImmune Way, Gaithersburg, MD 20878, USA.
Christopher J RhodesMedImmune, Cardiovascular and Metabolic Disease Research, 1 MedImmune Way, Gaithersburg, MD 20878, USA.
Joseph S GrimsbyMedImmune, Cardiovascular and Metabolic Disease Research, 1 MedImmune Way, Gaithersburg, MD 20878, USA.

Funding

METABOLIC CONTROL PROINSULIN BIOSYNTHESIS TRANSLATIONR01DK050610 · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · 1996 to 2005
$2.1M
Physiology CoreP30DK020595 · UNIVERSITY OF CHICAGO · 2025 to 2025
$1.4M
NIDDK NIH HHS P30 DK020595NIDDK NIH HHS R01 DK050610NIDDK NIH HHS R01 DK099359
6 · The paper itself

Abstract

backgroundAlthough the insulin-producing pancreatic β-cells are quite capable of adapting to both acute and chronic changes in metabolic demand, persistently high demand for insulin will ultimately lead to their progressive dysfunction and eventual loss. Recent and historical studies highlight the importance of 'resting' the β-cell as a means of preserving functional β-cell mass. SCOPE OF REVIEW: We provide experimental evidence to highlight the remarkable plasticity for insulin production and secretion by the pancreatic β-cell alongside some clinical evidence that supports leveraging this unique ability to preserve β-cell function. MAJOR

conclusionsTreatment strategies for type 2 diabetes mellitus (T2DM) targeted towards reducing the systemic metabolic burden, rather than demanding greater insulin production from an already beleaguered β-cell, should be emphasized to maintain endogenous insulin secretory function and delay the progression of T2DM.

Indexed as

AnimalsCell PlasticityDiabetes Mellitus, Type 2GlucoseHumansInsulinInsulin-Secreting CellsInsulin SecretionSignal TransductionGlucoseInsulinATF6, Activating Transcription Factor 6CHOP, CCAAT/Enhancer-Binding Homologous ProteinEPAC, Exchange Factor Directly Activated by cAMPEROβ1, ER-resident oxidoreductase β1GIP, Gastric Inhibitory PolypeptideGLP-1, Glucagon-like Peptide 1GLUT2, Glucose Transporter 2GSIS, Glucose Stimulated Insulin SecretionInsulin productionIREα, Inositol Requiring Enzyme αmTORC1, Mammalian Target of Rapamycin 1NEFA, Non-esterified Fatty AcidnH, Hill coefficientPERK, Protein Kinase RNA-like Endoplasmic Reticulum KinasePKA, Protein Kinase APKC, Protein Kinase CPLC, Phospholipase CROS, Reactive Oxygen SpeciesSNAP-25, Soluble NSF Attachment Protein 25SNARE, Soluble NSF Attachment Protein ReceptorSTZ, StreptozotocinT2DMT2DM, Type 2 Diabetes MellitusTRP, Transient Receptor PotentialVAMP-2, Vehicle Associated Membrane Protein 2VDCC, Voltage Dependent Calcium Channelβ-cell rest

Identifiers

PMID28951821
PMCPMC5605729
OpenAlexW2611238787

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.